Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
35.1%
% of GDOC's 39 holdings also in XLV
21.3%
% of XLV's 61 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in XLV |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.7% | 12.3% | 9.7% |
|
ABBVIE INC | 6.4% | 6.9% | 6.4% |
|
UNITEDHEALTH GROUP INC | 5.2% | 8.9% | 5.2% |
|
ABBOTT LABORATORIES | 5.2% | 4.1% | 4.1% |
|
MERCK & CO. INC. | 4.0% | 4.4% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to XLV
|
BOSTON SCIENTIFIC CORP | 5.6% |
 |
ASTRAZENECA PLC | 4.2% |
|
INSULET CORP | 4.1% |
 |
NOVO NORDISK A/S-B | 3.8% |
|
COOPER COS INC/THE | 3.5% |
|
BIOMARIN PHARMACEUTICAL INC | 3.3% |
 |
CSL LIMITED | 3.1% |
 |
LONZA GROUP AG-REG | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
VEEVA SYSTEMS INC-CLASS A | 2.5% |
GDOC Underweight Relative to XLV
|
JOHNSON & JOHNSON | -7.4% |
|
THERMO FISHER SCIENTIFIC INC | -3.7% |
|
UNITEDHEALTH GROUP INC | -3.7% |
|
AMGEN INC | -3.2% |
|
PFIZER INC | -2.8% |
|
ELI LILLY & CO | -2.6% |
|
GILEAD SCIENCES INC | -2.5% |
|
VERTEX PHARMACEUTICALS INC | -2.4% |
|
STRYKER CORP | -2.4% |
|
BRISTOL-MYERS SQUIBB CO | -2.3% |